Referral pattern to nephrologist and prognosis in diabetic kidney disease patients: Single center retrospective cohort study

PLoS One. 2023 Feb 24;18(2):e0282163. doi: 10.1371/journal.pone.0282163. eCollection 2023.

Abstract

Background: Management of diabetic kidney disease (DKD) to prevent end-stage kidney disease (ESKD) has become a major challenge for health care professionals. This study aims to investigate the characteristics of patients with DKD when they are first referred to a nephrologist and the subsequent prognoses.

Methods: A total of 307 patients who were referred to our department from October 2010 to September 2014 at Osaka General Medical Center were analyzed. Independent risk factors associated with renal replacement therapy (RRT) and cardiovascular composite events (CVE) following their nephrology referral were later identified using Cox proportional hazards analysis.

Results: Of 307 patients, 26 (8.5%), 67 (21.8%), 134 (43.6%), and 80 (26.1%) patients were categorized as having chronic kidney disease (CKD) stages 3a, 3b, 4, and 5, respectively. The median estimated glomerular filtration rate (eGFR) and urinary protein levels were 22.3 mL/min/1.73 m2 and 2.83 g/gCr, respectively, at the time of the nephrology referral. During the follow-up period (median, 30 months), 121 patients required RRT, and more than half of the patients with CKD stages 5 and 4 reached ESKD within 60 months following their nephrology referral; 30% and <10% of the patients with CKD stages 3b and 3a, respectively, required RRT within 60 months following their nephrology referral.

Conclusion: Patients with DKD were referred to nephrologist at CKD stage 4. Although almost half of the patients with CKD stage 5 at the time of nephrology referral required RRT within one-and-a-half years after the referral, kidney function of patients who were referred to nephrologist at CKD stage 3 and 4 were well preserved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Diabetic Nephropathies* / complications
  • Disease Progression
  • Glomerular Filtration Rate
  • Humans
  • Kidney Failure, Chronic* / therapy
  • Nephrologists
  • Nephrology*
  • Prognosis
  • Referral and Consultation
  • Renal Insufficiency, Chronic* / complications
  • Retrospective Studies

Grants and funding

Y.I received grant from Osaka Kidney Foundation (http://www.okf.ecnet.jp/). Grant number is OKF18-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.